Investment ThemesDetailed Quotes
Weight Loss Drugs Watchlist

GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.

  • 1857.242
  • -22.257-1.18%
Close Jul 24 16:00 ET
1877.311High1845.305Low
Constituent Stocks: 7Top Rising: PFE+1.63%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
PFEPfizer
29.9800.480+1.63%29.58M880.26M29.51029.50029.99029.310169.88B169.64B5.67B5.66B-0.17%+5.75%+7.11%+19.81%+12.38%-14.93%+7.30%5.50%0.52%Loss81.032.31%Drug Manufacturers - General
GPCRStructure Therapeutics
36.2500.310+0.86%510.21K18.32M35.70035.94036.39034.8732.02B1.39B55.69M38.40M-5.45%-13.34%-9.28%-6.91%-16.90%+2.20%-11.06%--1.33%LossLoss4.22%Biotechnology
AMGNAmgen
335.6102.370+0.71%2.46M824.83M333.250333.240337.180330.340180.03B179.53B536.43M534.94M-0.02%+4.33%+5.10%+25.19%+8.39%+47.15%+18.27%2.57%0.46%47.9426.872.05%Drug Manufacturers - General
NVONovo-Nordisk A/S
131.600-1.680-1.26%2.66M350.75M132.500133.280132.900130.920586.43B419.79B4.46B3.19B-2.82%-7.80%-10.42%+3.74%+15.52%+68.29%+28.13%1.04%0.08%45.4448.601.49%Biotechnology
LLYEli Lilly and Co
859.880-18.410-2.10%2.73M2.35B872.500878.290878.340854.270817.23B815.35B950.41M948.22M-5.05%-8.50%-4.94%+17.43%+33.65%+90.99%+48.02%0.55%0.29%126.64148.262.74%Drug Manufacturers - General
VKTXViking Therapeutics
50.410-1.130-2.19%3.63M197.85M50.84051.54052.18050.2705.56B5.26B110.27M104.36M+1.14%-13.07%+5.46%-32.16%+108.82%+253.01%+170.88%--3.47%LossLoss3.71%Biotechnology
ALTAltimmune
6.270-0.160-2.49%1.85M11.81M6.3006.4306.5906.240444.56M441.33M70.90M70.39M-16.29%-16.18%-15.38%-13.64%-33.58%+105.57%-44.27%--2.63%LossLoss5.44%Biotechnology

News

Comments

Read more